Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing

Nucleic Acids Research

Volumn 32, Issue 1, 2004, Pages 371-379

  Gomez, Dennis ^a   Lamarteleur, Thibault ^a   Lacroix, Laurent ^b   Mailliet, Patrick ^c   Mergny, Jean Louis ^b   Riou, Jean François ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRACO 19; GUANINE; LIGAND 12459; TELOMERASE; TELOMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; TELOMESTATIN; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; MOLECULAR CLONING; MOLECULAR STABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; RNA STRUCTURE;

ACRIDINES; ALTERNATIVE SPLICING; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; INTRONS; KINETICS; LIGANDS; OXAZOLES; QUINOLINIUM COMPOUNDS; RNA; SUBSTRATE SPECIFICITY; TELOMERASE; TRANSCRIPTION, GENETIC; TRIAZINES;

BRACON;

EID: 1242342930     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh181     Document Type: Article

References (29)

1. McEachern,M.J., Krauskopf,A. and Blackburn,E.H. (2000) Telomeres and their control. Annu. Rev. Genet., 34, 331-358.
2. Sharma,S., Raymond,E., Soda,H., Sun,D., Hilsenbeck,S.G., Sharma,A., Izbicka,E., Windle,B. and Von Hoff,D.D. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann. Oncol., 8, 1063-1074.
3. Neidle,S. and Parkinson,G.N. (2003) The structure of telomeric DNA. Curr. Opin. Struct. Biol., 13, 275-283.
4. Mergny,J.L., Riou,J.F., Mailliet,P., Teulade-Fichou,M.P. and Gilson,E. (2002) Natural and pharmacological regulation of telomerase. Nucleic Acids Res., 30, 839-865.
5. Neidle,S. and Parkinson,G. (2002) Telomere maintenance as a target for anticancer drug discovery. Nature Rev. Drug Discov., 1, 383-393.
6. Rezler,E.M., Bearss,D.J. and Hurley,L.H. (2002) Telomeres and telomerases as drug targets. Curr. Opin. Pharmacol, 2, 415-423.
7. Riou,J.F., Guittat,L., Mailliet,P., Laoui,A., Renou,E., Petitgenet,O., Megnin-Chanet,F., Hélène,C. and Mergny,J.L. (2002) Cell senescence and telomere shortening induced by a new series of specific G-quadruples DNA ligands. Proc. Natl Acad. Sci. USA, 99, 2672-2677.
8. Gomez,D., Mergny,J.L. and Riou,J.F. (2002) Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Res., 62, 3365-3368.
9. Shin-ya,K., Wierzba,K., Matsuo,K., Ohtani,T., Yamada,Y., Furihata,K., Hayakawa,Y. and Seto,H. (2001) Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc., 123, 1262-1263.
10. Gowan,S.M., Harrison,J.R., Patterson,L., Valenti,M., Read,M.A., Neidle,S. and Kelland,L.R. (2002) A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol. Pharmacol, 61, 1154-1162.
11. Mergny,J.L. and Maurizot,J.C. (2001) Fluorescence resonance energy transfer as a probe for G-quartet formation by a telomeric repeat. Chembiochem, Eur. J. Chem. Biol., 2. 124-132.
12. Mergny,J.L., Phan,A.T. and Lacroix,L. (1998) Following G-quartet formation by UV-spectroscopy. FEBS Lett., 435, 74-78.
13. Gomez,D., Aouali,N., Londono-Vallejo,A., Lacroix,L., Megnin-Chanet,F., Lemarteleur,T., Douarre,C., Shin-ya,K., Mailliet,P., Trentesaux,C. et al. (2003) Resistance to the short-term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J. Biol. Chem., 278, 5055-50562.
14. Yi,X., Shay,J.W. and Wright,W.E. (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res., 29, 4818-4825.
15. Wick,M., Zubov,D. and Hagen,G. (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 232, 97-106.
16. Kim,M.Y., Vankayalapati,H., Shin-Ya,K., Wierzba,K. and Hurley,L.H. (2002) Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J. Am. Chem. Soc., 124, 2098-2099.
17. Leem,S.H., Londono-Vallejo,J.A., Kim,J.H., Bui,H., Tubacher,E., Solomon,G., Park,J.E., Horikawa,I., Kouprina,N., Barrett,J.C. et al. (2002) The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene. 21, 769-777.
18. Phan,A.T. and Mergny,J.L. (2002) Human telomeric DNA: G-quadruples, i-motif and Watson-Crick double helix. Nucleic Acids Res., 30, 4618-4625.
19. Kim,M.Y., Gleason-Guzman,M., Izbicka,E., Nishioka,D. and Hurley,L.H. (2003) the different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular g-quadrplex structures. Cancer Res., 63, 3247-3256.
20. Rezler,E.M., Bearss,D.J. and Hurley,L.H. (2003) Telomere inhibition and telomere disruption as processes for drug targeting. Annu. Rev. Pharmacol. Toxicol., 43, 359-379.
21. Siddiqui-Jain,A., Grand,C.L., Bearss,D.J. and Hurley,L.H. (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl Acad. Sci. USA, 99, 11593-11598.
22. Darnell,J.C., Jensen,K.B., Jin,P., Brown,V., Warren,S.T. and Darnell,R.B. (2001) Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell, 107, 489-499.
23. Bonnal,S., Schaeffer,C., Créancier,L., Clamens,S., Moine,H., Prats,A.C. and Vagner,S. (2003) A single IRES containing a G-quartet RNA structure drives FGF-2 gene expression at four alternative translation initiation codons. J. Biol. Chem., 278, 39330-39336.
24. Sirand-Pugnet,P., Durosay,P., Brody,E. and Marie,J. (1995) An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken β-tropomyosin pre-mRNA. Nucleic Acids Res., 23, 3501-3507.
25. Cogan,J.D., Prince,M.A., Lekhakula,S., Bundey,S., Futrakul,A., McCarthy,E.M. and Phillips,J.A.,3rd (1997) A novel mechanism of aberrant pre-mRNA splicing in humans. Hum. Mol. Genet., 6, 909-912.
26. Fukuda,H., Katahira,M., Tsuchiya,N., Enokizono,Y., Sugimura,T., Nagao,M. and Nakagama,H. (2002) Unfolding of quadruplex structure in the G-rich strand of the minisatellite repeat by the binding protein UP1. Proc. Natl Acad. Sci. USA, 99, 12685-12690.
27. Dallaire,F., Dupuis,S., Fiset,S. and Chabot,B. (2000) Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem., 275, 14509-14516.
28. Cocco,M.J., Hanakahi,L.A., Huber,M.D. and Maizels,N. (2003) Specific interactions of distamycin with G-quadruplex DNA. Nucleic Acids Res., 31, 2944-2951.
29. Weisman-Shomer,P., Cohen,E., Hershco,I., Khateb,S., Wolfovitz-Barchad,O., Hurley,L. and Fry,M. (2003) The cationic porphyrin TMPyP4 destabilizes the tetraplex form of the fragile X syndrome expanded sequence d(CGG)n. Nucleic Acids Res., 31, 3963-3970.